Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Abstract | OBJECTIVE: METHODS: A 23-member committee, including general neurologists, pediatric neurologists, epileptologists, and doctors in pharmacy, evaluated the available evidence based on a structured literature review including MEDLINE, Current Contents, and Cochrane library for relevant articles from 1987 until September 2002, with selected manual searches up until 2003. RESULTS: CONCLUSIONS: The results of this evidence-based assessment provide guidelines for the prescription of AEDs for patients with newly diagnosed epilepsy and identify those seizure types and syndromes where more evidence is necessary.
|
Authors | J A French, A M Kanner, J Bautista, B Abou-Khalil, T Browne, C L Harden, W H Theodore, C Bazil, J Stern, S C Schachter, D Bergen, D Hirtz, G D Montouris, M Nespeca, B Gidal, W J Marks Jr, W R Turk, J H Fischer, B Bourgeois, A Wilner, R E Faught Jr, R C Sachdeo, A Beydoun, T A Glauser, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Quality Standards Subcommittee of the American Academy of Neurology, American Epilepsy Society |
Journal | Neurology
(Neurology)
Vol. 62
Issue 8
Pg. 1252-60
(Apr 27 2004)
ISSN: 1526-632X [Electronic] United States |
PMID | 15111659
(Publication Type: Comparative Study, Guideline, Journal Article, Practice Guideline, Review)
|
Chemical References |
- Acetates
- Amines
- Anticonvulsants
- Cyclohexanecarboxylic Acids
- Triazines
- Topiramate
- Fructose
- Carbamazepine
- gamma-Aminobutyric Acid
- Gabapentin
- Lamotrigine
- Oxcarbazepine
|
Topics |
- Acetates
(adverse effects, pharmacokinetics, therapeutic use)
- Acute Disease
- Adolescent
- Adult
- Amines
- Anticonvulsants
(adverse effects, pharmacokinetics, therapeutic use)
- Carbamazepine
(adverse effects, analogs & derivatives, pharmacokinetics, therapeutic use)
- Child
- Controlled Clinical Trials as Topic
(statistics & numerical data)
- Cyclohexanecarboxylic Acids
- Drug Interactions
- Epilepsy
(drug therapy)
- Evidence-Based Medicine
(statistics & numerical data)
- Fructose
(adverse effects, analogs & derivatives, pharmacokinetics, therapeutic use)
- Gabapentin
- Humans
- Lamotrigine
- Oxcarbazepine
- Topiramate
- Treatment Outcome
- Triazines
(adverse effects, pharmacokinetics, therapeutic use)
- gamma-Aminobutyric Acid
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|